Each year, the ASCPT Scientific Program Committee selects the top-scoring abstracts by trainee authors to honor them with the Presidential Trainee Award. Join ASCPT President, Mark J. Dresser, PhD, as he recognizes the 2023 Presidential Trainee Recipients.
2023 David J. Goldstein, MD, PhD Presidential Trainee Award PT-001 - MAXIMUM LIKELIHOOD ESTIMATION OF RENAL TRANSPORTER ONTOGENY PROFILES FOR PEDIATRIC PBPK MODELING. Porter Hunt, PhD
2023 Jason Morrow, MD Presidential Trainee Award Recipient PT-002 - OPTIMIZING CLINICAL TRIALS FOR DUCHENNE MUSCULAR DYSTROPHY USING MULTIVARIATE DISEASE PROGRESSION MODELS THAT BRIDGE A FUNCTIONAL ENDPOINT AND MRI RELAXOGRAPHY OF FIVE LEG MUSCLES. Deok Yong Yoon, PhD
PT-003 - EXPRESSION OF ABCB1 IS DECREASED IN PLACENTA OF WOMEN WITH AUTOIMMUNE DISEASE AND IN CYTOKINE- TREATED PLACENTAL EXPLANTS. Rashi Asthana-Nijjar
PT-004 - PROSPECTIVE VALIDATION OF MAXIMUM A POSTERIORI-BAYESIAN ESTIMATION OF TACROLIMUS EXPOSURE IN STABLE KIDNEY TRANSPLANT RECIPIENTS. Thomas Nguyen
PT-005 - MAJOR POTENTIAL DRUG-DRUG INTERACTIONS AMONG MEDICAID-INSURED CHILDREN IN THE OUTPATIENT SETTING. Kathryn Kyler, MD
PT-006 - A LESION-CENTRIC AND TARGET-SPECIFIC PKPD MODEL OF PYRAZINOIC ACID IN PATIENTS WITH TUBERCULOSIS. Anna Fochesato
PT-007 - VALIDATING THE PROTECTIVE CONCENTRATION OF PIPERAQUINE FOR MALARIA PREVENTION IN PREGNANT UGANDAN WOMEN. Emma Hughes, PhD
PT-008 - INFLUENCE OF MCT6 ON PLATINUM DISPOSITION AND OTOTOXICITY. Jeanine Day
PT-009 - ASSOCIATION BETWEEN TACROLIMUS AND CYP3A5 GENOTYPE IN PEDIATRIC KIDNEY TRANSPLANT. Alaa Alghamdi, PharmD
PT-010 - PREDICTING LINEZOLID-INDUCED HEMATOLOGIC TOXICITIES IN REAL-WORLD PATIENTS WITH HYBRID MODELING. Anu Patel, PharmD
PT-011 - COMPUTATIONAL SYSTEMS PHARMACOLOGY OF ANTIBODY-DRUG CONJUGATES. Inez Lam
PT-012 - POPULATION PHARMACOKINETICS OF ISONIAZID IN TBTC STUDY 31/ACTG A5349. Marjorie Z. Imperial, PhD
PT-013 - CONCURRENT GABAPENTIN AND OPIOID USE AND RISK OF MORTALITY IN MEDICARE RECIPIENTS WITH NON-CANCER PAIN. Meghan Corriere, MPH, PhD
PT-014 - A GLOBAL PROTEOMICS ANALYSIS OF THE ONTOGENY OF THE BLOOD-BRAIN BARRIER. Xujia Zhou
PT-015 - TRANSPORT AND KINASE DEPENDENT REGULATION OF TYROSINE KINASE INHIBITOR INDUCED CARDIOTOXICITY. Vivian Xu
PT-016 - POPULATION PHARMACOKINETIC MODELING TO GUIDE THE OPTIMAL DOSING FOR UNFRACTIONATED HEPARIN IN PEDIATRICS REQUIRING EXTRACORPOREAL MEMBRANE OXYGENATION. Ahmed Salem
PT-017 - CARDIOVASCULAR SAFETY OF CARFILZOMIB IN KOREA: RETROSPECTIVE COHORT STUDY USING A NATIONWIDE ADMINISTRATIVE CLAIM DATABASE. Hyun Kyung Lee, PharmD
PT-018 - OPTIMIZATION OF THE BETAMETHASONE DOSING REGIMEN DURING PREGNANCY: A COMBINED PLACENTA PERFUSION AND PREGNANCY PBPK MODELLING APPROACH. Joyce van der Heijden
PT-019 - ROLE OF ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B (OATP1B) IN HEPATIC UPTAKE AND ADVERSE EFFECTS OF AROMATASE INHIBITORS (AIS). Hanieh Taheri
PT-020 - FUNCTIONAL CHARACTERIZATION OF ELAVL2 REVEALED THE ROLE OF POST-TRANSCRIPTIONAL REGULATION IN PSYCHIATRIC DISORDERS AND ANTIDEPRESSANT TREATMENT RESPONSE. Trudy Philips
PT-021 - PHARMACOKINETIC (PK) BASIS OF STATIN DRUG-DRUG INTERACTION (DDI) INFORMATION IN FDA LABELS. James Mease, PharmD
PT-022 - OPTIMIZING LUMEFANTRINE DOSING IN YOUNG CHILDREN USING REAL WORLD DATA AND PHARMACOKINETIC/PHARMACODYNAMIC SIMULATIONS. Segolene Simeon, PharmD, PhD
PT-023 - DEVELOPMENT OF INTRANASAL PHYSIOLOGICALLY BASED NOSE TO BRAIN MODEL AND ITS APPLICATION TO CHARACTERIZE IN NEUROEPO ABSORPTION VIA NASAL ROUTE AND DISTRIBUTION TO LUMBAR CSF IN HEALTHY NON-HUMAN PRIMATES (CYANOMOLGUS MONKEY). Parsshava Mehta, PharmD
PT-024 - PHARMACOKINETICS AND TISSUE DISTRIBUTION OF A LIPID-BASED EXTENDED-RELEASE NANO-FORMULATION OF MO-OH-NAP TROPOLONE TO ENHANCE PULMONARY DELIVERY. Wafaa Aldhafiri
PT-025 - A NOVEL REGULATORY VARIANT PROMOTES CYP2D6 ALTERNATIVE SPLICING AND REDUCES FULL-LENGTH CYP2D6 PROTEIN LEVELS IN LIVER SAMPLES. Joseph Collins, PhD
PT-026 - TRANSCRIPTOMIC PROFILING OF PTRPD KNOCK-DOWN IN HUMAN IPSC-DERIVED NEURONS REVEALED A ROLE IN ALCOHOL USE DISORDER DRUG TREATMENT RESPONSE. Reem Neal, MD
PT-027 - DO GLUCOSE-LOWERING DRUGS AFFECT DRUG METABOLISM AND WARFARIN EFFICACY? Ann-Cathrine Dunvald, MD
PT-028 - CLINICAL ASSESSMENT OF THE DRUG INTERACTION POTENTIAL OF THE PSYCHOTROPIC NATURAL PRODUCT KRATOM (MITRAGYNA SPECIOSA). Rakshit Tanna
PT-029 - BUILDING A TELEHEALTH PHARMACOGENETIC TESTING PROGRAM IN RURAL AND PEDIATRIC PSYCHIATRY. Shayna Killam, MS, PharmD
